|Bid||0.00 x 1100|
|Ask||0.00 x 1100|
|Day's Range||125.77 - 130.00|
|52 Week Range||92.08 - 140.91|
|Beta (3Y Monthly)||1.30|
|PE Ratio (TTM)||34.35|
|Earnings Date||Jul 29, 2019 - Aug 2, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||137.00|
Zacks.com featured highlights include: Ross Stores, Shoe Carnival, Stitch Fix, Amedisys and NVR
Amedisys (AMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Amedisys Inc NASDAQ/NGS:AMEDView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding AMED totaled $64.97 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Paul Kusserow became the CEO of Amedisys, Inc. (NASDAQ:AMED) in 2014. This analysis aims first to contrast CEO...
Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR
We at Insider Monkey have gone over 738 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st. In this article, we look at what those funds think of Amedisys Inc (NASDAQ:AMED) based on that data. […]
Zacks.com featured highlights include: Intuit, Insperity, Amedisys, Pioneer Natural and Century Casinos
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the William Blair 2019 Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.